Diabetic Foot Ulcer Treatment Market to be Worth $7.77 Billion by 2030: Grand View Research, Inc.

SAN FRANCISCO, Aug. 25, 2022 /PRNewswire/ -- The global diabetic foot ulcer treatment market size is expected to reach USD 7.77 billion by 2030, registering a CAGR of 5.9% from 2022 to 2030, according to a new report by Grand View Research, Inc. Diabetes is one of the major causes of amputation, blindness, stroke, end-stage renal failure, kidney failure, and heart attacks in this region. According to the International Diabetes Federation, ~66 million people were suffering from diabetes in Europe in 2017. The number is expected to increase to ~81 million by 2045. The mortality rate associated with DFU is ~5% in the first 12 months and increases up to 42% by the end of 5 years.

Key Industry Insights & Findings from the report:

• By treatment, the biologics segment captured the largest revenue share in 2021 owing to its reduced wound healing time and increased platelet formation efficiency.
  
  
• Based on ulcer type, the neuro-ischemic ulcers segment held the dominant revenue share in 2021.
  
  
• The hospitals end-use segment accounted for the second-largest revenue share in 2021 due to the increased adoption rate of treatment and highly experienced staff.
  
  
• North America grabbed the largest revenue share in 2021 due to the presence of market players and improved treatment cost and reimbursement scenario.

Read 125 page full market research report, "Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report By Treatment (Biologics, Wound Care Dressings), By Ulcer Type (Neuro-ischemic, Ischemic, Neuropathic), By End-use, And Segment Forecasts, 2022 - 2030", published by Grand View Research.

Diabetic Foot Ulcer Treatment Market Growth & Trends

The biologics segment held the largest revenue share in 2021 and is expected to grow at the highest rate during the forecast period. Biologics include growth factors [such as Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF)], stem cells, and other anti-diabetic drugs. These agents help reduce hyperglycemia, increase oxygenation and circulation, and repair lost tissues. Therefore, they are increasingly being used for the management of wounds in different stages and are considered to be ideal for DFU treatment. Wound care dressings held the second-largest revenue share in 2021, followed by therapy devices and antibiotic medications.

Market players are constantly developing new and improved products to ensure quicker healing time for DFU. Companies like ConvaTec, Inc.; Acelity L.P. Inc.; 3M Healthcare; Coloplast Corp.; and Smith & Nephew Plc. are among the leaders in this market. Despite the Covid-19 outbreak, these players reported an increase in demand for their wound management products due to the increased complications of diabetic patients suffering from Covid-19 infection. The market was said to increase at a steady rate in 2021 as Covid-19 treated patients witnessed a rise in sugar levels leading to the onset of diabetes. For instance, the overall proportion of diabetic patients with Covid-19 ranged from 5% - 30% in Italy in 2020. Further, Smith and Nephew reported the sales of its newly launched wound healing product, PICO 7, to cross the 1 million mark in 2020. Hence, the market grew dramatically in 2020 and is estimated to stabilize during the forecast period.

Diabetic Foot Ulcer Treatment Market Segmentation

Grand View Research has segmented the global diabetic foot ulcer treatment market based on treatment, ulcer type, end-use, and region:

Diabetic Foot Ulcer Treatment Outlook (Revenue, USD Million, 2018 - 2030)

• Wound Care Dressings
• Alginate Dressings
• Hydrofiber Dressings
• Foam Dressings
• Film Dressing
• Hydrocolloid Dressings
• Surgical Dressings
• Hydrogel Dressings
• Biologics
• Growth Factors
• Skin Grafts
• Therapy Devices
• Negative Pressure Wound Therapy
• Ultrasound Therapy
• Antibiotic Medications
• Others

Diabetic Foot Ulcer Treatment Market - Ulcer Type Outlook (Revenue, USD Million, 2018 - 2030)

• Neuropathic Ulcers
• Ischemic Ulcers
• Neuro-ischemic Ulcers

Diabetic Foot Ulcer Treatment Market - End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Ambulatory Imaging Center
• Others

Diabetic Foot Ulcer Treatment Market - Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Poland
• Asia Pacific
• China
• Japan
• India
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

List of Key Players of the Diabetic Foot Ulcer Treatment Market

• ConvaTec, Inc.
• Acelity L.P., Inc.
• 3M Healthcare
• Coloplast Corp.
• Smith & Nephew Plc
• B Braun Melsungen AG
• Medline Industries, Inc.
• Organogenesis, Inc.
• Molnlycke Health Care AB
• Medtronic

Check out more related studies published by Grand View Research:

• Mouth Ulcers Treatment Market - The global mouth ulcers treatment market size is projected to reach USD 1.32 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 3.8% during the forecast period. Increasing geriatric population and rising awareness towards oral hygiene are among the key trends stimulating market growth.
  
  
• Psoriatic Arthritis Treatment Market - The global psoriatic arthritis treatment market size is expected to reach over USD 18.6 billion by 2026, according to a new study by Grand View Research Inc. It is projected to expand at a CAGR of 10.1% during the forecast period. Emergence of biosimilars, new product launches, and a rising consumer awareness are some of the key factors driving the growth.
  
  
• Biologics Market - The global biologics market is anticipated to reach USD 399.5 billion by 2025, according to a new report by Grand View Research, Inc. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine anticipated to fuel demand. Ever-increasing understanding of the cell physiology and stress, as well as the factors involved in protein production and heterologous gene expression have empowered the use of different living factories.

Browse through Grand View Research's  Pharmaceuticals Industry Research Reports.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]  
Web: https://www.grandviewresearch.com  
Grand View Compass | Astra ESG Solutions  
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg

SOURCE Grand View Research, Inc.